In the open-label FIBROMET trial, metformin treatment was associated with reductions in bone marrow fibrosis and downregulation of key oncogenic signaling pathways in patients wit ...
The JAK2 gene is a protein-coding gene of the Janus kinase family. It plays a role in cellular signaling. Evidence notes connections between this gene and some medical conditions. Variations in this ...
New research indicates that drugs that target a cell growth pathway known as the JAK-STAT pathway are likely to be effective against certain chronic leukemias. Researchers recently discovered that a ...
Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences, discusses ...
Positron emission tomography (PET) and estrogen receptor (ER) ligand in patients with invasive breast cancer. Germline single nucleotide polymorphisms (SNPs) in XRCC3, XRCC1, and XPD, and survival ...
Mechanisms of acquired afatinib resistance in HER2-positive breast cancer cells. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text ...
Eosinophilic cellulitis (EC) is a type 2 inflammatory disease that activates the JAK1/JAK2-STAT5 pathways, an analysis of skin biopsy specimens suggests. To better understand the pathogenesis of EC, ...
How the same enzyme helps protect brain cells from the destruction of Alzheimer's yet contributes to the blood vessel disease of diabetics is a puzzle Dr. Mario B. Marrero wants to solve. "I call JAK2 ...
Recently, the Food and Drug Administration (FDA) has approved Rinvoq for some people with atopic dermatitis. Rinvoq is a Janus kinase (JAK) inhibitor. These drugs work by blocking an important pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results